Control Versus Liberal Cardiac Frequency in Patients in Sepse With Atrial Fibrillation of High Ventricular Response

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 126 participants.

Also called NCT03715556

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 126 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03715556
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03715556. Randomized; double masking; primary purpose treatment. Start 2018-12-01 (anticipated); primary completion 2020-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Control Versus Liberal Cardiac Frequency in Patients in Sepse With Atrial Fibrillation of High Ventricular Response
Acronym
FAARV
Condition
Sepsis
Condition
Septic Shock
Condition
Atrial Fibrillation Rapid
Intervention (Drug)
Amiodarone
Intervention (Drug)
0.9% physiological solution
Lead sponsor
University of Sao Paulo General Hospital (class: other)

Record details

Record id
cardio:ct-nct03715556
Content hash
9e7c3f97994dcd80de52bc7027f415c3aa90ed748696d849c5ae1eb04c21ae59